Trial Profile
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Mar 2010
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary)
- Indications Menstrual migraine
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 11 Apr 2008 New trial record.